MEDICA 2018 is the leading international medical trade fair where thousands of companies from all over the world can showcase their medical inventions and innovations. Conferences, forums and special events are held throughout all four days of the fair.
June 8: Funding grant announced in Borås newspaper
The funding grant "Better Health 2018" that was recently co-awarded to PressCise and Södra Älvsborgs sjukhus has been announced in Borås Tidning. The purpose of the grant, valued at nearly 100,000 EUR, is to develop and clinically test a new and unique compression stocking.
PressCise CEO Andreas Nilsson and Co-inventor Josefinn Damm presented at the ICC Annual Meeting 2018 in Rotterdam, Netherlands, on a new innovation designed to prevent bandage slippage on the foot, allowing for normal ankle-foot movements and for patients to wear their normal shoes. Their presentation "Goodbye slippage: A new fusion to tackle bandage slippage on the foot" can be found online here!
Of 123 applications made to the Swedish call “Better health”, 22 received funding, of which PressCise and SÄS were awarded approximately 100 000 EUR to jointly develop and clinically test a new unique compression stocking. This new stocking will be based on PressCise-patented technology, used previously in our revolutionary bandage that is designed to always deliver the correct pressure. SWElife, Medtech4Health and Vinnova sponsored the call.
Read the news from Medtech West.
A fruitful week where PressCise AB exhibited at the EWMA Conference from 9-11 May 2018 in Krakow, Poland. During the conference, a scientific presentation was held by A. Nilsson and J. Damm, in the session: New technologies in Wound Care.
April 12: "Inventors from Herrljunga put pressure on medical problems"
Published article about PressCise in Borås Newspaper, Sweden.
Josefin Damm, Co-inventor and CTO of PressCise AB, had a short presentation at Sveriges Innovationsriksdag (Sweden's Innovation Parliament), Borås, Sweden
Sweden's Innovation Agency Vinnova and Medtech4Health have granted to fund our project, aiming to develop the market utilizing a patient perspective.
At UIP, CEO Andreas Nillsson held two talks; one at the main conference, and another at the ICC-session. Mr. Nilsson also received the Venartis® 2017 Phlebology Innovation Award, a travel stipend of 1,000 USD.
The healthcare company SanaFactur is now distributor of Lundatex® products on the German market. Their focus is wound care and compression products.
Our Lundatex® products are now FDA-registered and can be used on the US market.
Co-inventor and former CEO Josefin Damm returned after one year's parental leave. She returns as CTO, while Andreas Nilsson, continues as CEO.
© PressCise AB - edited June 2018